Showing results (221-230 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|January 9, 2024
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell LymphomaRawan G Faramand, Sae Bom Lee, Michael D Jain, et al.Blood Cancer Discovery|December 13, 2023
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylationNiklas Landberg, Thomas Köhnke, Yang Feng, et al.Blood Cancer Discovery|May 7, 2024
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin AxisNicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, et al.Blood Cancer Discovery|September 28, 2023
Understanding Infection Risk with Anti-BCMA Bispecific AntibodiesAlfred L Garfall, Edward A StadtmauerBlood Cancer Discovery|September 25, 2024
T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of TreatmentNiels W C J van de Donk, Leo Rasche, Surbhi Sidana, et al.Blood Cancer Discovery|March 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple MyelomaRintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.Blood Cancer Discovery|June 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple MyelomaMaximilian Merz, Tomas Jelinek, Thomas Pabst, et al.Blood Cancer Discovery|April 19, 2026
MYST acetyltransferases interact with SETBP1 and are a targetable therapeutic vulnerability in SETBP1-mutant leukemiaHanqian L Carlson, Thai T Nguyen, Samantha Tauchmann, et al.Pageof 34